default author photo

Minjun Dong

Shanghai Jiao Tong University (SJTU) - Department of Radiology

639 Zhizaoju Road

Shanghai, 200011

China

SCHOLARLY PAPERS

2

DOWNLOADS

136

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Neoadjuvant Immunochemotherapy for Locally Advanced Resectable Oral Squamous Cell Carcinoma: A Prospective Single-Arm Trial

Number of pages: 29 Posted: 21 Dec 2022
Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral Pathology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Radiology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Huangpu Branch, Shanghai Jiao Tong University (SJTU) - Department of Biostatistics, Shanghai Jiao Tong University (SJTU) - Department of Radiology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral Pathology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, 3D Medicines, Inc. - Medical Department, 3D Medicines, Inc. - Medical Department, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology and Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology
Downloads 103 (674,591)

Abstract:

Loading...

Neoadjuvant immunochemotherapy, PD-1 inhibitor, Oral squamous cell carcinoma, Major pathological response

2.

Apatinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck: A Single-Arm, Phase II Study

Number of pages: 34 Posted: 07 Oct 2020
Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Radiology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology and Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology
Downloads 33 (1,277,121)

Abstract:

Loading...

adenoid cystic carcinoma, recurrent or metastatic, Apatinib